Balchem (BCPC)
(Delayed Data from NSDQ)
$170.55 USD
-1.48 (-0.86%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $170.43 -0.12 (-0.07%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$170.55 USD
-1.48 (-0.86%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $170.43 -0.12 (-0.07%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Zacks News
Blachem (BCPC) Q3 Earnings Beat Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 9.46% and -6.21%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
The Market Timing Secrets No One Talks About - October 31, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Blachem (BCPC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Time the Markets Like an Investing Pro - October 11, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
When Does Market Timing Actually Work? - September 23, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Truth About Market Timing - August 30, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
New Strong Sell Stocks for August 13th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for August 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
The Keys to Successful Timing the Markets - August 06, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Blachem (BCPC) Q2 Earnings Beat Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 10.00% and -4.60%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Blachem (BCPC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ecolab's Nalco Water to Boost Public Health With New Offering
by Zacks Equity Research
Ecolab's (ECL) Nalco Water introduces a new offering - LegionGuard LG25 that will help to protect public health.
Blachem (BCPC) Upgraded to Buy: Here's Why
by Zacks Equity Research
Blachem (BCPC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Blachem (BCPC) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of 5.80% and -4.25%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Blachem (BCPC) Q1 Earnings Expected to Decline
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured expert Kevin Matras highlights: Balchem, Methode Electronics, Chemed, Ubiquiti Networks and HEXO
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Balchem, Methode Electronics, Chemed, Ubiquiti Networks and HEXO
5 Stocks in Focus on New Analysts Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
Surging Earnings Estimates Signal Upside for Blachem (BCPC) Stock
by Zacks Equity Research
Blachem (BCPC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Earnings Preview: Blachem (BCPC) Q4 Earnings Expected to Decline
by Zacks Equity Research
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moving Average Crossover Alert: Balchem Corporation
by Zacks Equity Research
Balchem Corporation could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.